237 filings
Page 4 of 12
8-K
zt980axn
31 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
mdu40f74wb9lvv6
29 Jul 15
Results of Operations and Financial Condition
12:00am
8-K
nyggf1294rps5tmgr
9 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
niit5ltigb4fs3
15 Jun 15
Other Events
12:00am
8-K
tux53l347q1j
2 Jun 15
Departure of Directors or Certain Officers
12:00am
8-K
3mw4ec xie
5 May 15
Results of Operations and Financial Condition
12:00am
8-K
braj2 iex7
9 Apr 15
Results of Operations and Financial Condition
12:00am
8-K
305th
18 Feb 15
Results of Operations and Financial Condition
12:00am
8-K
w0eme40h6z5h6wm6
13 Jan 15
Entry into a Material Definitive Agreement
12:00am
8-K
tlypvt
8 Jan 15
Other Events
12:00am
8-K
s22lk4bsc 37o
6 Jan 15
The Medicines Company Announces Intention to Offer $300 Million of Convertible Notes
12:00am
8-K
yqjdx ekr6
6 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
hhh hd0hxua05vx
5 Nov 14
Regulation FD Disclosure
12:00am
8-K
eh7 y83n1b00wcd
22 Oct 14
The Medicines Company Reports Third Quarter and First Nine Months 2014 Results
12:00am
8-K
zvtcz 696pda9
11 Aug 14
FDA Approves The Medicines Company's ORBACTIV™ (oritavancin) for Use in Acute Bacterial Skin and Skin Structure Infections
12:00am
8-K
9oxk7u7
23 Jul 14
The Medicines Company Reports Second Quarter and First Half 2014 Results
12:00am
8-K
nqy5qg2iql2k9qyu
30 May 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
n2gv4m118
7 May 14
Completion of Acquisition or Disposition of Assets
12:00am
8-K
ca6qo4fl1 cqutm9yrbu
23 Apr 14
The Medicines Company Adds Novel, Approved, Surgical Sealant to Its Surgical Hemostasis Portfolio
12:00am
8-K
aqovc7mgz
23 Apr 14
The Medicines Company Reports First Quarter 2014 Financial Results
12:00am